Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
NEUROGENESIS |
176 |
1402 |
1.168e-25 |
5.437e-22 |
2 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
109 |
788 |
4.498e-19 |
6.977e-16 |
3 |
CIRCULATORY SYSTEM DEVELOPMENT |
109 |
788 |
4.498e-19 |
6.977e-16 |
4 |
NEURON DIFFERENTIATION |
116 |
874 |
7.933e-19 |
9.228e-16 |
5 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
179 |
1672 |
2.016e-18 |
1.738e-15 |
6 |
CELL DEVELOPMENT |
160 |
1426 |
2.241e-18 |
1.738e-15 |
7 |
CELLULAR COMPONENT MORPHOGENESIS |
117 |
900 |
2.818e-18 |
1.873e-15 |
8 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
81 |
513 |
9.043e-18 |
5.26e-15 |
9 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
120 |
957 |
1.717e-17 |
8.878e-15 |
10 |
REGULATION OF CELL DIFFERENTIATION |
162 |
1492 |
3.047e-17 |
1.418e-14 |
11 |
VASCULATURE DEVELOPMENT |
75 |
469 |
7.597e-17 |
3.213e-14 |
12 |
REGULATION OF CELL DEVELOPMENT |
107 |
836 |
2.682e-16 |
1.04e-13 |
13 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
98 |
750 |
1.391e-15 |
4.979e-13 |
14 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
140 |
1275 |
2.43e-15 |
8.075e-13 |
15 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
129 |
1142 |
4.091e-15 |
1.269e-12 |
16 |
REGULATION OF NEURON DIFFERENTIATION |
79 |
554 |
8.152e-15 |
2.371e-12 |
17 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
118 |
1021 |
1.371e-14 |
3.752e-12 |
18 |
TISSUE DEVELOPMENT |
155 |
1518 |
3.483e-14 |
9.003e-12 |
19 |
BIOLOGICAL ADHESION |
117 |
1032 |
6.924e-14 |
1.696e-11 |
20 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
95 |
771 |
1.464e-13 |
3.407e-11 |
21 |
TISSUE MORPHOGENESIS |
74 |
533 |
2.373e-13 |
5.258e-11 |
22 |
NEURON DEVELOPMENT |
87 |
687 |
3.593e-13 |
7.598e-11 |
23 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
142 |
1395 |
6.192e-13 |
1.253e-10 |
24 |
NEURON PROJECTION DEVELOPMENT |
74 |
545 |
7.34e-13 |
1.423e-10 |
25 |
LOCOMOTION |
120 |
1114 |
1.131e-12 |
2.105e-10 |
26 |
POSITIVE REGULATION OF LOCOMOTION |
62 |
420 |
1.507e-12 |
2.697e-10 |
27 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
100 |
872 |
2.68e-12 |
4.618e-10 |
28 |
BLOOD VESSEL MORPHOGENESIS |
56 |
364 |
3.448e-12 |
5.73e-10 |
29 |
NEURON PROJECTION MORPHOGENESIS |
59 |
402 |
6.754e-12 |
1.084e-09 |
30 |
REGULATION OF DEVELOPMENTAL GROWTH |
48 |
289 |
7.737e-12 |
1.2e-09 |
31 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
62 |
437 |
8.61e-12 |
1.292e-09 |
32 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
65 |
472 |
1.019e-11 |
1.482e-09 |
33 |
PROTEIN PHOSPHORYLATION |
104 |
944 |
1.097e-11 |
1.547e-09 |
34 |
CELL MOTILITY |
95 |
835 |
1.534e-11 |
2.04e-09 |
35 |
LOCALIZATION OF CELL |
95 |
835 |
1.534e-11 |
2.04e-09 |
36 |
REGULATION OF CELL PROJECTION ORGANIZATION |
72 |
558 |
1.756e-11 |
2.249e-09 |
37 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
83 |
689 |
1.789e-11 |
2.249e-09 |
38 |
INTRACELLULAR SIGNAL TRANSDUCTION |
150 |
1572 |
1.92e-11 |
2.351e-09 |
39 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
58 |
408 |
3.781e-11 |
4.511e-09 |
40 |
TAXIS |
63 |
464 |
3.926e-11 |
4.567e-09 |
41 |
CELL PROJECTION ORGANIZATION |
99 |
902 |
4.423e-11 |
4.92e-09 |
42 |
ANGIOGENESIS |
47 |
293 |
4.441e-11 |
4.92e-09 |
43 |
REGULATION OF CELL MORPHOGENESIS |
70 |
552 |
7.455e-11 |
8.067e-09 |
44 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
92 |
823 |
8.502e-11 |
8.991e-09 |
45 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
172 |
1929 |
1.307e-10 |
1.329e-08 |
46 |
HEART DEVELOPMENT |
62 |
466 |
1.314e-10 |
1.329e-08 |
47 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
53 |
368 |
1.638e-10 |
1.622e-08 |
48 |
HEAD DEVELOPMENT |
82 |
709 |
1.83e-10 |
1.774e-08 |
49 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
47 |
306 |
2.025e-10 |
1.885e-08 |
50 |
REGULATION OF CELL PROLIFERATION |
141 |
1496 |
1.999e-10 |
1.885e-08 |
51 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
103 |
983 |
2.532e-10 |
2.31e-08 |
52 |
EMBRYO DEVELOPMENT |
96 |
894 |
2.922e-10 |
2.615e-08 |
53 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
73 |
609 |
3.873e-10 |
3.4e-08 |
54 |
MORPHOGENESIS OF AN EPITHELIUM |
55 |
400 |
4.332e-10 |
3.733e-08 |
55 |
POSITIVE REGULATION OF CELL PROLIFERATION |
89 |
814 |
5.472e-10 |
4.629e-08 |
56 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
61 |
472 |
5.998e-10 |
4.896e-08 |
57 |
ORGAN MORPHOGENESIS |
91 |
841 |
5.923e-10 |
4.896e-08 |
58 |
REGULATION OF EXTENT OF CELL GROWTH |
24 |
101 |
9.449e-10 |
7.58e-08 |
59 |
REGULATION OF CHEMOTAXIS |
33 |
180 |
1.099e-09 |
8.664e-08 |
60 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
46 |
312 |
1.236e-09 |
9.439e-08 |
61 |
TUBE DEVELOPMENT |
67 |
552 |
1.237e-09 |
9.439e-08 |
62 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
38 |
232 |
1.759e-09 |
1.32e-07 |
63 |
POSITIVE REGULATION OF CELL COMMUNICATION |
140 |
1532 |
1.859e-09 |
1.373e-07 |
64 |
RESPONSE TO GROWTH FACTOR |
60 |
475 |
2.024e-09 |
1.471e-07 |
65 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
86 |
801 |
2.624e-09 |
1.878e-07 |
66 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
170 |
1977 |
2.68e-09 |
1.889e-07 |
67 |
MUSCLE STRUCTURE DEVELOPMENT |
56 |
432 |
2.739e-09 |
1.902e-07 |
68 |
EMBRYONIC MORPHOGENESIS |
65 |
539 |
2.854e-09 |
1.953e-07 |
69 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
161 |
1848 |
3.059e-09 |
2.033e-07 |
70 |
REGULATION OF TRANSPORT |
158 |
1804 |
3.048e-09 |
2.033e-07 |
71 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
158 |
1805 |
3.169e-09 |
2.077e-07 |
72 |
POSITIVE REGULATION OF GENE EXPRESSION |
153 |
1733 |
3.282e-09 |
2.121e-07 |
73 |
FOREBRAIN DEVELOPMENT |
49 |
357 |
4.142e-09 |
2.64e-07 |
74 |
MESENCHYMAL CELL DIFFERENTIATION |
27 |
134 |
4.277e-09 |
2.689e-07 |
75 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
44 |
303 |
4.553e-09 |
2.825e-07 |
76 |
CELL PART MORPHOGENESIS |
72 |
633 |
5.005e-09 |
3.064e-07 |
77 |
SKELETAL SYSTEM DEVELOPMENT |
57 |
455 |
6.962e-09 |
4.207e-07 |
78 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
150 |
1710 |
7.386e-09 |
4.406e-07 |
79 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
29 |
156 |
8.015e-09 |
4.721e-07 |
80 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
143 |
1618 |
1.085e-08 |
6.309e-07 |
81 |
REGULATION OF GROWTH |
71 |
633 |
1.147e-08 |
6.556e-07 |
82 |
CELL CELL ADHESION |
69 |
608 |
1.155e-08 |
6.556e-07 |
83 |
REGULATION OF AXONOGENESIS |
30 |
168 |
1.176e-08 |
6.592e-07 |
84 |
ACTIN FILAMENT BASED PROCESS |
56 |
450 |
1.198e-08 |
6.634e-07 |
85 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
60 |
498 |
1.212e-08 |
6.636e-07 |
86 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
43 |
303 |
1.366e-08 |
7.389e-07 |
87 |
REGULATION OF CELLULAR COMPONENT SIZE |
46 |
337 |
1.469e-08 |
7.858e-07 |
88 |
PHOSPHORYLATION |
115 |
1228 |
1.617e-08 |
8.548e-07 |
89 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
39 |
262 |
1.71e-08 |
8.938e-07 |
90 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
32 |
191 |
1.915e-08 |
9.899e-07 |
91 |
REGULATION OF CELL SIZE |
30 |
172 |
2.059e-08 |
1.053e-06 |
92 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
153 |
1784 |
2.293e-08 |
1.16e-06 |
93 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
45 |
337 |
4.106e-08 |
2.055e-06 |
94 |
EPITHELIUM DEVELOPMENT |
93 |
945 |
4.311e-08 |
2.134e-06 |
95 |
CYTOSKELETON ORGANIZATION |
85 |
838 |
4.483e-08 |
2.15e-06 |
96 |
REGULATION OF CELL ADHESION |
69 |
629 |
4.481e-08 |
2.15e-06 |
97 |
BEHAVIOR |
60 |
516 |
4.442e-08 |
2.15e-06 |
98 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
143 |
1656 |
4.656e-08 |
2.211e-06 |
99 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
73 |
684 |
5.573e-08 |
2.619e-06 |
100 |
MESENCHYME DEVELOPMENT |
31 |
190 |
5.97e-08 |
2.778e-06 |
101 |
NEGATIVE REGULATION OF AXON EXTENSION |
13 |
38 |
6.383e-08 |
2.941e-06 |
102 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
122 |
1360 |
6.562e-08 |
2.994e-06 |
103 |
RESPONSE TO ENDOGENOUS STIMULUS |
128 |
1450 |
7.557e-08 |
3.414e-06 |
104 |
UROGENITAL SYSTEM DEVELOPMENT |
41 |
299 |
7.822e-08 |
3.5e-06 |
105 |
RESPONSE TO OXYGEN LEVELS |
42 |
311 |
8.406e-08 |
3.725e-06 |
106 |
CARDIAC CHAMBER DEVELOPMENT |
26 |
144 |
8.694e-08 |
3.816e-06 |
107 |
TUBE MORPHOGENESIS |
43 |
323 |
8.937e-08 |
3.886e-06 |
108 |
REGULATION OF AXON GUIDANCE |
13 |
39 |
9.091e-08 |
3.917e-06 |
109 |
CELL SUBSTRATE ADHESION |
28 |
164 |
9.678e-08 |
4.131e-06 |
110 |
REGULATION OF MEMBRANE POTENTIAL |
44 |
343 |
1.86e-07 |
7.867e-06 |
111 |
MUSCLE TISSUE DEVELOPMENT |
38 |
275 |
1.901e-07 |
7.97e-06 |
112 |
STEM CELL DIFFERENTIATION |
30 |
190 |
2.041e-07 |
8.48e-06 |
113 |
NEGATIVE REGULATION OF CELL ADHESION |
33 |
223 |
2.441e-07 |
1.005e-05 |
114 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
25 |
144 |
3.345e-07 |
1.365e-05 |
115 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
26 |
154 |
3.452e-07 |
1.373e-05 |
116 |
AMEBOIDAL TYPE CELL MIGRATION |
26 |
154 |
3.452e-07 |
1.373e-05 |
117 |
NEURON PROJECTION GUIDANCE |
31 |
205 |
3.45e-07 |
1.373e-05 |
118 |
NEGATIVE REGULATION OF AXONOGENESIS |
16 |
65 |
3.499e-07 |
1.38e-05 |
119 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
22 |
117 |
4.071e-07 |
1.592e-05 |
120 |
REGULATION OF CELLULAR LOCALIZATION |
113 |
1277 |
4.188e-07 |
1.624e-05 |
121 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
94 |
1008 |
4.373e-07 |
1.682e-05 |
122 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
88 |
926 |
4.672e-07 |
1.782e-05 |
123 |
ARTERY DEVELOPMENT |
17 |
75 |
5.412e-07 |
2.047e-05 |
124 |
NEURON MIGRATION |
21 |
110 |
5.711e-07 |
2.143e-05 |
125 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
18 |
84 |
6.161e-07 |
2.293e-05 |
126 |
SENSORY ORGAN DEVELOPMENT |
55 |
493 |
6.208e-07 |
2.293e-05 |
127 |
MUSCLE ORGAN DEVELOPMENT |
37 |
277 |
6.435e-07 |
2.358e-05 |
128 |
HEART MORPHOGENESIS |
31 |
212 |
7.304e-07 |
2.655e-05 |
129 |
CARDIAC SEPTUM DEVELOPMENT |
18 |
85 |
7.416e-07 |
2.675e-05 |
130 |
NEGATIVE CHEMOTAXIS |
12 |
39 |
7.641e-07 |
2.735e-05 |
131 |
REGULATION OF HOMEOSTATIC PROCESS |
51 |
447 |
8.119e-07 |
2.884e-05 |
132 |
NEGATIVE REGULATION OF AXON GUIDANCE |
10 |
27 |
9.282e-07 |
3.272e-05 |
133 |
MUSCLE CELL DIFFERENTIATION |
33 |
237 |
1.005e-06 |
3.517e-05 |
134 |
POSITIVE REGULATION OF GROWTH |
33 |
238 |
1.106e-06 |
3.842e-05 |
135 |
CELL CELL SIGNALING |
75 |
767 |
1.171e-06 |
4.036e-05 |
136 |
TELENCEPHALON DEVELOPMENT |
32 |
228 |
1.224e-06 |
4.189e-05 |
137 |
NEGATIVE REGULATION OF LOCOMOTION |
35 |
263 |
1.399e-06 |
4.752e-05 |
138 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
26 |
166 |
1.522e-06 |
5.132e-05 |
139 |
GLAND DEVELOPMENT |
46 |
395 |
1.591e-06 |
5.325e-05 |
140 |
MAMMARY GLAND DEVELOPMENT |
21 |
117 |
1.641e-06 |
5.455e-05 |
141 |
SINGLE ORGANISM CELL ADHESION |
51 |
459 |
1.784e-06 |
5.889e-05 |
142 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
32 |
232 |
1.798e-06 |
5.891e-05 |
143 |
RESPONSE TO WOUNDING |
59 |
563 |
1.922e-06 |
6.255e-05 |
144 |
POSITIVE REGULATION OF AXON EXTENSION |
11 |
36 |
2.393e-06 |
7.541e-05 |
145 |
REGULATION OF CYTOSKELETON ORGANIZATION |
54 |
502 |
2.399e-06 |
7.541e-05 |
146 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
11 |
36 |
2.393e-06 |
7.541e-05 |
147 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
104 |
1192 |
2.376e-06 |
7.541e-05 |
148 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
38 |
304 |
2.372e-06 |
7.541e-05 |
149 |
POSITIVE REGULATION OF CHEMOTAXIS |
21 |
120 |
2.508e-06 |
7.832e-05 |
150 |
LOCOMOTORY BEHAVIOR |
27 |
181 |
2.532e-06 |
7.853e-05 |
151 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
144 |
1791 |
2.678e-06 |
8.252e-05 |
152 |
COGNITION |
33 |
251 |
3.625e-06 |
0.0001103 |
153 |
OVULATION CYCLE |
20 |
113 |
3.61e-06 |
0.0001103 |
154 |
PEPTIDYL TYROSINE MODIFICATION |
27 |
186 |
4.291e-06 |
0.0001296 |
155 |
POSITIVE REGULATION OF AXONOGENESIS |
15 |
69 |
4.356e-06 |
0.0001308 |
156 |
CEREBRAL CORTEX DEVELOPMENT |
19 |
105 |
4.483e-06 |
0.0001337 |
157 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
100 |
1152 |
4.674e-06 |
0.0001385 |
158 |
CELL ACTIVATION |
58 |
568 |
5.253e-06 |
0.0001547 |
159 |
IMMUNE SYSTEM DEVELOPMENT |
59 |
582 |
5.462e-06 |
0.0001599 |
160 |
FOREBRAIN CELL MIGRATION |
14 |
62 |
5.642e-06 |
0.0001641 |
161 |
NEGATIVE REGULATION OF CELL ACTIVATION |
24 |
158 |
6.549e-06 |
0.0001893 |
162 |
REGULATION OF SYSTEM PROCESS |
53 |
507 |
6.834e-06 |
0.0001963 |
163 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
20 |
118 |
7.148e-06 |
0.000204 |
164 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
91 |
1036 |
8.022e-06 |
0.0002262 |
165 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
91 |
1036 |
8.022e-06 |
0.0002262 |
166 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
35 |
285 |
8.694e-06 |
0.0002437 |
167 |
AORTA DEVELOPMENT |
11 |
41 |
9.745e-06 |
0.0002715 |
168 |
GROWTH |
45 |
410 |
9.816e-06 |
0.0002719 |
169 |
CAMP METABOLIC PROCESS |
10 |
34 |
1.011e-05 |
0.0002784 |
170 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
56 |
554 |
1.026e-05 |
0.0002808 |
171 |
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
6 |
11 |
1.036e-05 |
0.0002818 |
172 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
18 |
102 |
1.141e-05 |
0.0003087 |
173 |
EXTRACELLULAR MATRIX ASSEMBLY |
7 |
16 |
1.156e-05 |
0.0003108 |
174 |
PALLIUM DEVELOPMENT |
23 |
153 |
1.206e-05 |
0.0003226 |
175 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
88 |
1004 |
1.234e-05 |
0.000328 |
176 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
18 |
103 |
1.312e-05 |
0.0003469 |
177 |
MULTICELLULAR ORGANISMAL SIGNALING |
20 |
123 |
1.356e-05 |
0.0003565 |
178 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
22 |
144 |
1.428e-05 |
0.0003732 |
179 |
REGULATION OF VASCULATURE DEVELOPMENT |
30 |
233 |
1.496e-05 |
0.000389 |
180 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
18 |
104 |
1.506e-05 |
0.0003892 |
181 |
REGULATION OF EPITHELIAL CELL MIGRATION |
24 |
166 |
1.54e-05 |
0.000396 |
182 |
CEREBRAL CORTEX CELL MIGRATION |
11 |
43 |
1.602e-05 |
0.0004096 |
183 |
NEURAL CREST CELL MIGRATION |
12 |
51 |
1.674e-05 |
0.0004233 |
184 |
NEGATIVE REGULATION OF CHEMOTAXIS |
12 |
51 |
1.674e-05 |
0.0004233 |
185 |
KIDNEY EPITHELIUM DEVELOPMENT |
20 |
125 |
1.733e-05 |
0.0004358 |
186 |
REGULATION OF BLOOD CIRCULATION |
35 |
295 |
1.84e-05 |
0.0004604 |
187 |
CARDIAC VENTRICLE DEVELOPMENT |
18 |
106 |
1.971e-05 |
0.0004887 |
188 |
REGULATION OF ORGANELLE ORGANIZATION |
99 |
1178 |
1.987e-05 |
0.0004887 |
189 |
REGULATION OF INTRACELLULAR TRANSPORT |
60 |
621 |
1.977e-05 |
0.0004887 |
190 |
DEVELOPMENTAL GROWTH |
38 |
333 |
1.996e-05 |
0.0004887 |
191 |
GLAND MORPHOGENESIS |
17 |
97 |
2.178e-05 |
0.0005306 |
192 |
REGULATION OF KINASE ACTIVITY |
71 |
776 |
2.202e-05 |
0.0005337 |
193 |
CORONARY VASCULATURE DEVELOPMENT |
10 |
37 |
2.307e-05 |
0.0005563 |
194 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
33 |
274 |
2.326e-05 |
0.0005579 |
195 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
21 |
138 |
2.36e-05 |
0.0005631 |
196 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
27 |
204 |
2.399e-05 |
0.0005696 |
197 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
14 |
70 |
2.478e-05 |
0.0005853 |
198 |
RESPONSE TO KETONE |
25 |
182 |
2.523e-05 |
0.0005929 |
199 |
EPITHELIAL CELL PROLIFERATION |
16 |
89 |
2.722e-05 |
0.0006364 |
200 |
CELL JUNCTION ASSEMBLY |
20 |
129 |
2.778e-05 |
0.0006464 |
201 |
EYE DEVELOPMENT |
37 |
326 |
2.875e-05 |
0.0006655 |
202 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
61 |
643 |
2.914e-05 |
0.0006713 |
203 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
10 |
38 |
2.977e-05 |
0.0006823 |
204 |
CELL PROLIFERATION |
63 |
672 |
3.095e-05 |
0.0006991 |
205 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
119 |
1492 |
3.077e-05 |
0.0006991 |
206 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
23 |
162 |
3.091e-05 |
0.0006991 |
207 |
REGULATION OF CELL GROWTH |
42 |
391 |
3.205e-05 |
0.0007203 |
208 |
RESPONSE TO EXTERNAL STIMULUS |
140 |
1821 |
3.621e-05 |
0.0007986 |
209 |
ENSHEATHMENT OF NEURONS |
16 |
91 |
3.619e-05 |
0.0007986 |
210 |
AXON ENSHEATHMENT |
16 |
91 |
3.619e-05 |
0.0007986 |
211 |
REGULATION OF CELL CELL ADHESION |
41 |
380 |
3.579e-05 |
0.0007986 |
212 |
REGULATION OF CALCIUM ION TRANSPORT |
27 |
209 |
3.702e-05 |
0.0008124 |
213 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
22 |
153 |
3.743e-05 |
0.0008176 |
214 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
20 |
133 |
4.356e-05 |
0.0009472 |
215 |
ESTROUS CYCLE |
7 |
19 |
4.394e-05 |
0.000951 |
216 |
SINGLE ORGANISM BEHAVIOR |
41 |
384 |
4.547e-05 |
0.000977 |
217 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
12 |
56 |
4.557e-05 |
0.000977 |
218 |
ACTIN FILAMENT BASED MOVEMENT |
16 |
93 |
4.769e-05 |
0.001018 |
219 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
69 |
767 |
4.884e-05 |
0.001024 |
220 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
17 |
103 |
4.843e-05 |
0.001024 |
221 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
17 |
103 |
4.843e-05 |
0.001024 |
222 |
REGULATED EXOCYTOSIS |
28 |
224 |
4.872e-05 |
0.001024 |
223 |
REGULATION OF OSSIFICATION |
24 |
178 |
4.933e-05 |
0.001029 |
224 |
BONE DEVELOPMENT |
22 |
156 |
5.058e-05 |
0.001051 |
225 |
INOSITOL LIPID MEDIATED SIGNALING |
19 |
124 |
5.159e-05 |
0.001067 |
226 |
REGULATION OF NEUROTRANSMITTER LEVELS |
25 |
190 |
5.226e-05 |
0.001076 |
227 |
REGULATION OF BODY FLUID LEVELS |
50 |
506 |
5.432e-05 |
0.001108 |
228 |
ACTION POTENTIAL |
16 |
94 |
5.455e-05 |
0.001108 |
229 |
CELL GROWTH |
20 |
135 |
5.412e-05 |
0.001108 |
230 |
CARDIAC CHAMBER MORPHOGENESIS |
17 |
104 |
5.495e-05 |
0.001112 |
231 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
71 |
799 |
5.616e-05 |
0.001113 |
232 |
IN UTERO EMBRYONIC DEVELOPMENT |
35 |
311 |
5.569e-05 |
0.001113 |
233 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
94 |
1135 |
5.621e-05 |
0.001113 |
234 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
58 |
616 |
5.622e-05 |
0.001113 |
235 |
NEURAL CREST CELL DIFFERENTIATION |
14 |
75 |
5.552e-05 |
0.001113 |
236 |
LEUKOCYTE ACTIVATION |
43 |
414 |
5.73e-05 |
0.00113 |
237 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
6 |
14 |
5.828e-05 |
0.001144 |
238 |
APPENDAGE DEVELOPMENT |
23 |
169 |
6.068e-05 |
0.001181 |
239 |
LIMB DEVELOPMENT |
23 |
169 |
6.068e-05 |
0.001181 |
240 |
EPITHELIAL CELL DIFFERENTIATION |
49 |
495 |
6.149e-05 |
0.001192 |
241 |
REGULATION OF MAPK CASCADE |
61 |
660 |
6.213e-05 |
0.0012 |
242 |
EMBRYONIC HEMOPOIESIS |
7 |
20 |
6.438e-05 |
0.001233 |
243 |
AXONAL FASCICULATION |
7 |
20 |
6.438e-05 |
0.001233 |
244 |
REGULATION OF CELL DEATH |
116 |
1472 |
6.491e-05 |
0.001238 |
245 |
WOUND HEALING |
47 |
470 |
6.752e-05 |
0.001279 |
246 |
POSITIVE REGULATION OF CELL GROWTH |
21 |
148 |
6.789e-05 |
0.001279 |
247 |
DEVELOPMENTAL MATURATION |
25 |
193 |
6.777e-05 |
0.001279 |
248 |
REGULATION OF CELL ACTIVATION |
48 |
484 |
6.96e-05 |
0.001306 |
249 |
ADHERENS JUNCTION ASSEMBLY |
9 |
34 |
7.088e-05 |
0.001325 |
250 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
28 |
229 |
7.217e-05 |
0.00134 |
251 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
11 |
50 |
7.284e-05 |
0.00134 |
252 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
11 |
50 |
7.284e-05 |
0.00134 |
253 |
RESPONSE TO PROGESTERONE |
11 |
50 |
7.284e-05 |
0.00134 |
254 |
CONNECTIVE TISSUE DEVELOPMENT |
25 |
194 |
7.378e-05 |
0.001352 |
255 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
14 |
77 |
7.502e-05 |
0.001369 |
256 |
STRIATED MUSCLE CELL DIFFERENTIATION |
23 |
173 |
8.742e-05 |
0.001589 |
257 |
CELL CHEMOTAXIS |
22 |
162 |
8.985e-05 |
0.001627 |
258 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
20 |
140 |
9.108e-05 |
0.001643 |
259 |
CELL JUNCTION ORGANIZATION |
24 |
185 |
9.173e-05 |
0.001648 |
260 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
34 |
307 |
9.708e-05 |
0.001737 |
261 |
REGULATION OF HEART CONTRACTION |
27 |
221 |
9.772e-05 |
0.001742 |
262 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
109 |
1381 |
0.0001025 |
0.00182 |
263 |
SECRETION |
55 |
588 |
0.0001033 |
0.001828 |
264 |
REGULATION OF GTPASE ACTIVITY |
61 |
673 |
0.0001076 |
0.001896 |
265 |
ADULT LOCOMOTORY BEHAVIOR |
14 |
80 |
0.0001154 |
0.002026 |
266 |
REGULATION OF CYTOPLASMIC TRANSPORT |
47 |
481 |
0.0001175 |
0.002056 |
267 |
NEGATIVE REGULATION OF GROWTH |
28 |
236 |
0.000122 |
0.002126 |
268 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
20 |
143 |
0.0001227 |
0.002131 |
269 |
ADHERENS JUNCTION ORGANIZATION |
13 |
71 |
0.0001247 |
0.002157 |
270 |
SKELETAL SYSTEM MORPHOGENESIS |
25 |
201 |
0.0001311 |
0.00226 |
271 |
SPROUTING ANGIOGENESIS |
10 |
45 |
0.0001411 |
0.002399 |
272 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
22 |
167 |
0.0001413 |
0.002399 |
273 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
6 |
16 |
0.0001412 |
0.002399 |
274 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
6 |
16 |
0.0001412 |
0.002399 |
275 |
NEGATIVE REGULATION OF TRANSPORT |
45 |
458 |
0.0001436 |
0.00243 |
276 |
MODULATION OF SYNAPTIC TRANSMISSION |
33 |
301 |
0.000148 |
0.002495 |
277 |
CIRCULATORY SYSTEM PROCESS |
38 |
366 |
0.0001525 |
0.002545 |
278 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
15 |
92 |
0.0001526 |
0.002545 |
279 |
VENTRICULAR SEPTUM DEVELOPMENT |
11 |
54 |
0.0001523 |
0.002545 |
280 |
CELL FATE COMMITMENT |
27 |
227 |
0.0001534 |
0.00255 |
281 |
EMBRYONIC ORGAN DEVELOPMENT |
41 |
406 |
0.0001559 |
0.002582 |
282 |
RESPONSE TO ESTRADIOL |
20 |
146 |
0.0001637 |
0.002701 |
283 |
REGULATION OF CALCIUM ION IMPORT |
16 |
103 |
0.0001673 |
0.00275 |
284 |
REGULATION OF TRANSFERASE ACTIVITY |
79 |
946 |
0.0001701 |
0.002787 |
285 |
REGULATION OF SECRETION |
62 |
699 |
0.0001727 |
0.00282 |
286 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
12 |
64 |
0.0001781 |
0.002897 |
287 |
REGULATION OF HYDROLASE ACTIVITY |
104 |
1327 |
0.0001932 |
0.003111 |
288 |
RESPONSE TO ESTROGEN |
26 |
218 |
0.0001929 |
0.003111 |
289 |
ACTIN MEDIATED CELL CONTRACTION |
13 |
74 |
0.0001926 |
0.003111 |
290 |
NEURAL TUBE FORMATION |
15 |
94 |
0.0001952 |
0.003133 |
291 |
DIGESTIVE SYSTEM DEVELOPMENT |
20 |
148 |
0.0001973 |
0.003154 |
292 |
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
6 |
17 |
0.000208 |
0.003315 |
293 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
11 |
56 |
0.0002141 |
0.003389 |
294 |
OUTFLOW TRACT MORPHOGENESIS |
11 |
56 |
0.0002141 |
0.003389 |
295 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
17 |
116 |
0.0002189 |
0.003447 |
296 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
42 |
426 |
0.0002193 |
0.003447 |
297 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
13 |
75 |
0.0002213 |
0.003467 |
298 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
9 |
39 |
0.000223 |
0.003471 |
299 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
9 |
39 |
0.000223 |
0.003471 |
300 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
116 |
1518 |
0.0002255 |
0.003498 |
301 |
SPINAL CORD DEVELOPMENT |
16 |
106 |
0.0002351 |
0.003631 |
302 |
MUSCLE CONTRACTION |
27 |
233 |
0.0002359 |
0.003631 |
303 |
NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
7 |
24 |
0.0002365 |
0.003631 |
304 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
12 |
66 |
0.000241 |
0.003689 |
305 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
11 |
57 |
0.0002522 |
0.003848 |
306 |
REGULATION OF HEART RATE |
14 |
86 |
0.0002549 |
0.003876 |
307 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
16 |
107 |
0.0002625 |
0.003967 |
308 |
PEPTIDYL AMINO ACID MODIFICATION |
71 |
841 |
0.0002635 |
0.003967 |
309 |
POSITIVE REGULATION OF CELL ADHESION |
38 |
376 |
0.0002631 |
0.003967 |
310 |
TUBE FORMATION |
18 |
129 |
0.0002707 |
0.004063 |
311 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
9 |
40 |
0.0002738 |
0.004092 |
312 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
64 |
740 |
0.0002744 |
0.004092 |
313 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
8 |
32 |
0.000276 |
0.004095 |
314 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
12 |
67 |
0.000279 |
0.004095 |
315 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
50 |
541 |
0.0002789 |
0.004095 |
316 |
HOMEOSTASIS OF NUMBER OF CELLS |
22 |
175 |
0.0002783 |
0.004095 |
317 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
50 |
541 |
0.0002789 |
0.004095 |
318 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
13 |
77 |
0.0002899 |
0.004229 |
319 |
RESPONSE TO LIPID |
74 |
888 |
0.0002894 |
0.004229 |
320 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
37 |
365 |
0.000297 |
0.004298 |
321 |
CARDIAC SEPTUM MORPHOGENESIS |
10 |
49 |
0.0002971 |
0.004298 |
322 |
MUSCLE CELL MIGRATION |
6 |
18 |
0.0002974 |
0.004298 |
323 |
REGULATION OF RESPONSE TO STRESS |
112 |
1468 |
0.0003083 |
0.004442 |
324 |
PLATELET ACTIVATION |
19 |
142 |
0.0003206 |
0.004604 |
325 |
REGULATION OF CELL JUNCTION ASSEMBLY |
12 |
68 |
0.000322 |
0.00461 |
326 |
REGULATION OF ERK1 AND ERK2 CASCADE |
27 |
238 |
0.0003324 |
0.004649 |
327 |
LEARNING |
18 |
131 |
0.0003282 |
0.004649 |
328 |
RENAL TUBULE DEVELOPMENT |
13 |
78 |
0.0003305 |
0.004649 |
329 |
REGULATION OF ION HOMEOSTASIS |
24 |
201 |
0.0003288 |
0.004649 |
330 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
9 |
41 |
0.0003337 |
0.004649 |
331 |
REGULATION OF STEM CELL PROLIFERATION |
14 |
88 |
0.0003259 |
0.004649 |
332 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
87 |
1087 |
0.0003324 |
0.004649 |
333 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
18 |
131 |
0.0003282 |
0.004649 |
334 |
LACTATION |
9 |
41 |
0.0003337 |
0.004649 |
335 |
RESPONSE TO HORMONE |
74 |
893 |
0.0003413 |
0.00474 |
336 |
NEURON RECOGNITION |
8 |
33 |
0.0003468 |
0.004802 |
337 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
23 |
190 |
0.0003558 |
0.004912 |
338 |
LYMPHOCYTE ACTIVATION |
35 |
342 |
0.000358 |
0.004929 |
339 |
REGULATION OF SYNAPSE ASSEMBLY |
13 |
79 |
0.0003759 |
0.00516 |
340 |
METENCEPHALON DEVELOPMENT |
15 |
100 |
0.0003904 |
0.005333 |
341 |
NEGATIVE REGULATION OF GENE EXPRESSION |
113 |
1493 |
0.0003912 |
0.005333 |
342 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
26 |
228 |
0.000392 |
0.005333 |
343 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
16 |
111 |
0.0004014 |
0.005445 |
344 |
REGULATION OF CELL MATRIX ADHESION |
14 |
90 |
0.0004133 |
0.005557 |
345 |
LENS MORPHOGENESIS IN CAMERA TYPE EYE |
6 |
19 |
0.0004144 |
0.005557 |
346 |
PROTEIN AUTOPHOSPHORYLATION |
23 |
192 |
0.0004137 |
0.005557 |
347 |
MESONEPHROS DEVELOPMENT |
14 |
90 |
0.0004133 |
0.005557 |
348 |
ARTERY MORPHOGENESIS |
10 |
51 |
0.0004178 |
0.005586 |
349 |
SYNAPSE ORGANIZATION |
19 |
145 |
0.0004191 |
0.005588 |
350 |
FOREBRAIN NEURON DEVELOPMENT |
8 |
34 |
0.0004317 |
0.005739 |
351 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
18 |
134 |
0.0004343 |
0.005757 |
352 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
62 |
724 |
0.0004405 |
0.005822 |
353 |
POSITIVE REGULATION OF KINASE ACTIVITY |
45 |
482 |
0.0004445 |
0.005859 |
354 |
REGULATION OF VASCULOGENESIS |
5 |
13 |
0.0004578 |
0.006018 |
355 |
MEMBRANE DEPOLARIZATION |
11 |
61 |
0.0004667 |
0.0061 |
356 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
11 |
61 |
0.0004667 |
0.0061 |
357 |
ADULT BEHAVIOR |
18 |
135 |
0.0004757 |
0.006183 |
358 |
METAL ION TRANSPORT |
52 |
582 |
0.0004751 |
0.006183 |
359 |
NEGATIVE REGULATION OF CELL GROWTH |
21 |
170 |
0.0004806 |
0.006229 |
360 |
RESPONSE TO ABIOTIC STIMULUS |
82 |
1024 |
0.0004831 |
0.006231 |
361 |
MUSCLE SYSTEM PROCESS |
30 |
282 |
0.0004835 |
0.006231 |
362 |
REGULATION OF SYNAPSE ORGANIZATION |
16 |
113 |
0.0004919 |
0.006323 |
363 |
CELLULAR RESPONSE TO LIPID |
43 |
457 |
0.0005019 |
0.006428 |
364 |
REGULATION OF PROTEIN LOCALIZATION |
77 |
950 |
0.0005029 |
0.006428 |
365 |
RESPONSE TO ALCOHOL |
36 |
362 |
0.0005105 |
0.006508 |
366 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
31 |
296 |
0.0005135 |
0.006528 |
367 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
72 |
876 |
0.0005153 |
0.006533 |
368 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
27 |
0.0005243 |
0.006612 |
369 |
SUBSTRATE DEPENDENT CELL MIGRATION |
7 |
27 |
0.0005243 |
0.006612 |
370 |
CARDIAC VENTRICLE MORPHOGENESIS |
11 |
62 |
0.0005394 |
0.006784 |
371 |
EXOCYTOSIS |
32 |
310 |
0.000541 |
0.006785 |
372 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
24 |
208 |
0.0005438 |
0.006802 |
373 |
SECOND MESSENGER MEDIATED SIGNALING |
20 |
160 |
0.0005564 |
0.00694 |
374 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
18 |
137 |
0.0005688 |
0.007077 |
375 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
10 |
53 |
0.0005766 |
0.007098 |
376 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
10 |
53 |
0.0005766 |
0.007098 |
377 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
10 |
53 |
0.0005766 |
0.007098 |
378 |
RHYTHMIC PROCESS |
31 |
298 |
0.0005755 |
0.007098 |
379 |
REGULATION OF PEPTIDE SECRETION |
24 |
209 |
0.0005829 |
0.007156 |
380 |
REGULATION OF METAL ION TRANSPORT |
33 |
325 |
0.0005973 |
0.007294 |
381 |
RESPIRATORY SYSTEM DEVELOPMENT |
23 |
197 |
0.0005958 |
0.007294 |
382 |
NEPHRON DEVELOPMENT |
16 |
115 |
0.0005994 |
0.007301 |
383 |
REGULATION OF CELL SUBSTRATE ADHESION |
21 |
173 |
0.0006071 |
0.007375 |
384 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
43 |
462 |
0.0006277 |
0.007606 |
385 |
REGULATION OF IMMUNE SYSTEM PROCESS |
106 |
1403 |
0.0006318 |
0.007635 |
386 |
NEGATIVE REGULATION OF BLOOD CIRCULATION |
8 |
36 |
0.000652 |
0.007759 |
387 |
REGULATION OF SENSORY PERCEPTION |
8 |
36 |
0.000652 |
0.007759 |
388 |
RESPONSE TO BMP |
14 |
94 |
0.0006489 |
0.007759 |
389 |
CELLULAR RESPONSE TO BMP STIMULUS |
14 |
94 |
0.0006489 |
0.007759 |
390 |
REGULATION OF SENSORY PERCEPTION OF PAIN |
8 |
36 |
0.000652 |
0.007759 |
391 |
POSITIVE CHEMOTAXIS |
8 |
36 |
0.000652 |
0.007759 |
392 |
TRANSMISSION OF NERVE IMPULSE |
10 |
54 |
0.0006731 |
0.007969 |
393 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
40 |
422 |
0.0006719 |
0.007969 |
394 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
5 |
14 |
0.0006798 |
0.008028 |
395 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
9 |
45 |
0.0006918 |
0.008149 |
396 |
REGULATION OF ION TRANSPORT |
52 |
592 |
0.0007027 |
0.008257 |
397 |
MUSCLE CELL DEVELOPMENT |
17 |
128 |
0.0007064 |
0.008279 |
398 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
12 |
74 |
0.000715 |
0.008318 |
399 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
11 |
64 |
0.0007133 |
0.008318 |
400 |
CELLULAR RESPONSE TO STRESS |
116 |
1565 |
0.000713 |
0.008318 |
401 |
REGULATION OF SYNAPTIC PLASTICITY |
18 |
140 |
0.0007378 |
0.00854 |
402 |
SYNAPTIC SIGNALING |
40 |
424 |
0.0007365 |
0.00854 |
403 |
REGULATION OF GLIAL CELL PROLIFERATION |
6 |
21 |
0.0007535 |
0.0087 |
404 |
CHEMICAL HOMEOSTASIS |
71 |
874 |
0.0007745 |
0.008898 |
405 |
HEART PROCESS |
13 |
85 |
0.0007744 |
0.008898 |
406 |
ACTIN CYTOSKELETON REORGANIZATION |
10 |
55 |
0.0007824 |
0.008967 |
407 |
CAMP MEDIATED SIGNALING |
8 |
37 |
0.000792 |
0.009054 |
408 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
18 |
141 |
0.000803 |
0.009157 |
409 |
RESPONSE TO RETINOIC ACID |
15 |
107 |
0.0008101 |
0.009216 |
410 |
CELLULAR RESPONSE TO RETINOIC ACID |
11 |
65 |
0.0008164 |
0.009264 |
411 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
9 |
46 |
0.0008183 |
0.009264 |
412 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
36 |
372 |
0.000841 |
0.009498 |
413 |
HOMEOSTATIC PROCESS |
101 |
1337 |
0.0008511 |
0.009589 |
414 |
CELL MATRIX ADHESION |
16 |
119 |
0.0008755 |
0.00984 |
415 |
RESPONSE TO ACID CHEMICAL |
32 |
319 |
0.0008803 |
0.00987 |
416 |
POSITIVE REGULATION OF MAPK CASCADE |
43 |
470 |
0.0008878 |
0.009931 |